Clinical trial
Use of Ivermectin as a Therapeutic Option for Patients With COVID-19
NCT04445311 is registered in ClinicalTrials.gov with Zagazig University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Use of Ivermectin as a Therapeutic Option for Patients With COVID-19
- Lead sponsor
- Zagazig University
- Phase
- Phase 2/3
- Overall status
- Unknown status
- Start date
- May 31, 2020
- Completion date
- August 15, 2020
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid